- 0
- 9
What changed
Each line against the same period a year earlier, as the company reported both in its latest filing. The math is under every line.
Latest quarter vs the same quarter a year earlier
10-Q filed 2026-10-22 ↗| Quarter ended | 2025-09-30 | 2026-09-30 | Change |
|---|---|---|---|
| Revenue(64,601 − 51,242) ÷ |51,242| × 100 = +26.1% ($ millions) | $51.2B | $64.6B | +26.1% |
| Operating income(12,988 − 20,535) ÷ |20,535| × 100 = −36.8% ($ millions) | $20.5B | $13.0B | −36.8% |
| Net income(9,860 − 2,709) ÷ |2,709| × 100 = +264.0% ($ millions) | $2.7B | $9.9B | +264.0% |
| Diluted earnings per share(3.83 − 1.05) ÷ |1.05| × 100 = +264.8% ($ a share) | $1.05 | $3.83 | +264.8% |
| Diluted share count (weighted)(2,573 − 2,572) ÷ |2,572| × 100 = 0.0% (millions of shares) | 2.57B | 2.57B | 0.0% |
| Research and development(20,054 − 15,144) ÷ |15,144| × 100 = +32.4% ($ millions) | $15.1B | $20.1B | +32.4% |
Latest fiscal year vs the year before
10-K filed 2026-01-29 ↗| Year ended | 2024-12-31 | 2025-12-31 | Change |
|---|---|---|---|
| Revenue(200,966 − 164,501) ÷ |164,501| × 100 = +22.2% ($ millions) | $164.5B | $201.0B | +22.2% |
| Operating income(83,276 − 69,380) ÷ |69,380| × 100 = +20.0% ($ millions) | $69.4B | $83.3B | +20.0% |
| Net income(60,458 − 62,360) ÷ |62,360| × 100 = −3.1% ($ millions) | $62.4B | $60.5B | −3.1% |
| Diluted earnings per share(23.49 − 23.86) ÷ |23.86| × 100 = −1.6% ($ a share) | $23.86 | $23.49 | −1.6% |
| Diluted share count (weighted)(2,574 − 2,614) ÷ |2,614| × 100 = −1.5% (millions of shares) | 2.61B | 2.57B | −1.5% |
| Research and development(57,372 − 43,873) ÷ |43,873| × 100 = +30.8% ($ millions) | $43.9B | $57.4B | +30.8% |
| Operating cash flow(115,800 − 91,328) ÷ |91,328| × 100 = +26.8% ($ millions) | $91.3B | $115.8B | +26.8% |
Metrics from the filings
Each value carries the period it covers and the form it was reported in.
| Metric | Value | Period end | Form |
|---|---|---|---|
| Revenue | $201.0B | 2025-12-31 | 10-K |
| Net income | $60.5B | 2025-12-31 | 10-K |
| Operating cash flow | $115.8B | 2025-12-31 | 10-K |
| Research and development | $57.4B | 2025-12-31 | 10-K |
| Total assets | $366.0B | 2025-12-31 | 10-K |
| Cash and cash equivalents | $35.9B | 2025-12-31 | 10-K |
| Revenue | $64.6B | 2026-09-30 | 10-Q |
| Net income | $9.9B | 2026-09-30 | 10-Q |
| Revenue, prior year | $164.5B | 2024-12-31 | 10-K |
| Net income, prior year | $62.4B | 2024-12-31 | 10-K |
| Revenue, same quarter prior year | $51.2B | 2025-09-30 | 10-Q |
Videos on META
No video on META yet. Follow the company and you will hear when there is one.